BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37131218)

  • 21. Are nonfunctioning adrenal incidentalomas really nonfunctioning? A retrospective single-center study.
    Güneş E; Güneş M
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9895-9901. PubMed ID: 37916357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are comorbidities of patients with adrenal incidentaloma tied to sex?
    Puglisi S; Barač Nekić A; Morelli V; Alessi Y; Fosci M; Pani A; Zibar Tomsic K; Palmieri S; Ferraù F; Pia A; Chiodini I; Kastelan D; Reimondo G; Terzolo M
    Front Endocrinol (Lausanne); 2024; 15():1385808. PubMed ID: 38808113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of cortisol cosecretion on non-ACTH-stimulated adrenal venous sampling in primary aldosteronism: a retrospective cohort study.
    Heinrich DA; Quinkler M; Adolf C; Handgriff L; Müller L; Schneider H; Sturm L; Künzel H; Seidensticker M; Deniz S; Ladurner R; Beuschlein F; Reincke M
    Eur J Endocrinol; 2022 Nov; 187(5):637-650. PubMed ID: 36070424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis.
    Pelsma ICM; Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
    Eur J Endocrinol; 2023 Oct; 189(4):S88-S101. PubMed ID: 37801655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of intraoperative cortisol levels after preoperative hydrocortisone administration versus placebo in patients without adrenal insufficiency undergoing endoscopic transsphenoidal removal of nonfunctioning pituitary adenomas: a double-blind randomized trial.
    Lee HC; Yoon HK; Kim JH; Kim YH; Park HP
    J Neurosurg; 2020 Jan; 134(2):526-534. PubMed ID: 31978882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early assessment of postoperative adrenal function is necessary after adrenalectomy for mild autonomous cortisol secretion.
    Foster T; Bancos I; McKenzie T; Dy B; Thompson G; Lyden M
    Surgery; 2021 Jan; 169(1):150-154. PubMed ID: 32693952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study.
    Morelli V; Reimondo G; Giordano R; Della Casa S; Policola C; Palmieri S; Salcuni AS; Dolci A; Mendola M; Arosio M; Ambrosi B; Scillitani A; Ghigo E; Beck-Peccoz P; Terzolo M; Chiodini I
    J Clin Endocrinol Metab; 2014 Mar; 99(3):827-34. PubMed ID: 24423350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?
    Rebelo JFD; Costa JM; Junqueira FD; Fonseca AO; de Almeida ABABS; Moraes AB; Vieira Neto L
    Clin Endocrinol (Oxf); 2023 May; 98(5):662-669. PubMed ID: 36514987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion.
    Favero V; Eller-Vainicher C; Morelli V; Cairoli E; Salcuni AS; Scillitani A; Corbetta S; Casa SD; Muscogiuri G; Persani L; Chiodini I
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e623-e632. PubMed ID: 37738555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difference of coronary artery disease severity, extent and plaque characteristics between patients with hypertension, diabetes mellitus or dyslipidemia.
    Tomizawa N; Nojo T; Inoh S; Nakamura S
    Int J Cardiovasc Imaging; 2015 Jan; 31(1):205-12. PubMed ID: 25262436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics.
    Morelli V; Palmieri S; Salcuni AS; Eller-Vainicher C; Cairoli E; Zhukouskaya V; Scillitani A; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Feb; 168(2):235-41. PubMed ID: 23169694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
    Schinke C; Hesse S; Stoppe M; Meyer K; Schmidt E; Orthgiess J; Bechmann L; Bresch A; Rullmann M; Luthardt J; Sabri O; Blüher M; Kratzsch J; Then Bergh F
    Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pituitary-adrenal glucocorticoid response is altered by gender and disease.
    Greenspan SL; Rowe JW; Maitland LA; McAloon-Dyke M; Elahi D
    J Gerontol; 1993 May; 48(3):M72-7. PubMed ID: 8387077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No Postoperative Adrenal Insufficiency in a Patient with Unilateral Cortisol-Secreting Adenomas Treated with Mifepristone Before Surgery.
    Saroka RM; Kane MP; Robinson L; Busch RS
    Clin Med Insights Endocrinol Diabetes; 2016; 9():31-6. PubMed ID: 27486349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical features and outcomes of surgical versus conservative management in patients with subclinical Cushing's syndrome].
    Liu MS; Zhang WJ; Zhu KY; Feng WH; Huang H; Zhu DL; Li P
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2834-2840. PubMed ID: 32988143
    [No Abstract]   [Full Text] [Related]  

  • 37. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
    Brox-Torrecilla N; García Cano AM; Valderrábano P; Quintero Tobar A; Escobar-Morreale HF; Araujo-Castro M
    Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between the clinical characteristics of patients with adrenal incidentalomas and those with hypertension-associated adrenal tumors in a single center in Japan.
    Aoe M; Okada A; Usui T; Manaka K; Nangaku M; Makita N
    Endocr J; 2020 Jun; 67(6):645-654. PubMed ID: 32213723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
    Araujo-Castro M; García Cano AM; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.